Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7641668 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL543862 | 0.83 | ALDH1A1 (0.69) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL20156765 | 0.81 | ALDH1A1 (0.58) | ALDH1A1TP53CYP3A4MGLL | |
| Water SCHEMBL27681480 | 0.81 | ALDH1A1 (0.67) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL5098181 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL12219026 | 0.80 | ALDH1A1 (0.67) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL2048901 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL5098171 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL15617 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TP53CYP3A4MGLLTSHR | |
| SCHEMBL15440362 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100047904-A1 | MATERIALS, METHODS AND SYSTEMS FOR PURIFICATION AND/OR SEPARATION | KINTAN PTY. LTD. (AU) | 2010-02-25 | — | — | US | claimed |
| EP-2091623-A1 | MATERIALS, METHODS AND SYSTEMS FOR PURIFICATION AND/OR SEPERATION | FORDE, Gareth Michael (AU) | 2009-08-26 | — | — | EP | claimed |
| WO-2008058349-A1 | MATERIALS, METHODS AND SYSTEMS FOR PURIFICATION AND/OR SEPERATION | FORDE GARETH MICHAEL (AU) | 2008-05-22 | — | — | WO | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250118226-A1 | WASH-OFF LABEL | UPM RAFLATAC OY (FI) | 2025-04-10 | — | — | US | disclosed |
| EP-4469532-A1 | WASH-OFF LABEL | UPM Raflatac Oy (FI) | 2024-12-04 | — | — | EP | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| US-11754563-B2 | Porous membranes with a polymer grafting, methods and uses thereof | Global Life Sciences Solutions Operations UK Ltd (GB) | 2023-09-12 | — | — | US | disclosed |
| WO-2023144446-A1 | WASH-OFF LABEL | UPM RAFLATAC OY (FI) | 2023-08-03 | — | — | WO | disclosed |
| EP-3221698-B1 | POROUS MEMBRANES WITH A POLYMER GRAFTING, METHODS AND USES THEREOF | Global Life Sciences Solutions Operations UK Ltd (GB) | 2021-02-17 | — | — | EP | disclosed |
| EP-2773455-B1 | PROTEIN CHROMATOGRAPHY MATRICES WITH HYDROPHILIC COPOLYMER COATINGS | PURDUE RESEARCH FOUNDATION (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20070040145-A1 | e.g.block copolymer of methoxypolyethylene glycol mono (meth)acrylate with monomers selected from unsaturated ether, alcohol, ester, nitrile, carboxy, anhydride etc.; excellent in thermal properties, physical properties and ion conductivity | NIPPON SODA CO., LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-20070040145-A1 | e.g.block copolymer of methoxypolyethylene glycol mono (meth)acrylate with monomers selected from unsaturated ether, alcohol, ester, nitrile, carboxy, anhydride etc.; excellent in thermal properties, physical properties and ion conductivity | NIPPON SODA CO., LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-7176268-B2 | Prepolymers for improved surface modification of contact lenses | BAUSCH & LOMB INCORPORATED (US) | 2007-02-13 | — | — | US | disclosed |
| US-7176268-B2 | Prepolymers for improved surface modification of contact lenses | BAUSCH & LOMB INCORPORATED (US) | 2007-02-13 | — | — | US | disclosed |
| WO-2007016371-A2 | READILY SHAPEABLE XEROGELS HAVING CONTROLLABLY DELAYED SWELLING PROPERTIES | AKINA, INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070031499-A1 | Readily shapeable xerogels having controllably delayed swelling properties | AKINA, INC. | 2007-02-08 | — | — | US | disclosed |
| US-20070031499-A1 | Readily shapeable xerogels having controllably delayed swelling properties | AKINA, INC. | 2007-02-08 | — | — | US | disclosed |
| US-7172851-B2 | Light sensitive composition, planographic printing plate material, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-02-06 | — | — | US | disclosed |
| US-7172851-B2 | Light sensitive composition, planographic printing plate material, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070031499-A1 | Readily shapeable xerogels having controllably delayed swelling properties | SMARCA2, SMARCA4, SMARCE1 | ALDH1A1 4329/4885TP53 1189/4885CYP3A4 2170/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | ALDH1A1 3285/4885TP53 2914/4885CYP3A4 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.